Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.81 USD | -1.23% | +1.09% | +47.53% |
May. 02 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
May. 02 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.53% | 1.89B | |
+9.02% | 106B | |
+0.40% | 104B | |
+6.78% | 23.25B | |
-13.83% | 22.5B | |
-6.96% | 18.7B | |
-37.08% | 17.95B | |
-11.24% | 16.99B | |
+7.32% | 14.26B | |
+39.29% | 12.76B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- RBC Lifts Price Target on Agios Pharmaceuticals to $42 From $40 as Phase 2 Trial of Sickle Cell Disease Treatment Meets Primary Endpoint; Outperform Kept